Ampait, Dexie O.
HRN: 26-46-37 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/01/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/01/2025
01/08/2025
IV
1130mg
Q6hours
PCAP-D
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes